Substance P Participates in Immune-mediated Hepatic Injury Induced by Concanavalin A in Mice and Stimulates Cytokine Synthesis in Kupffer Cells
Overview
Authors
Affiliations
Studies have indicated that the immune system plays a pivotal role in hepatitis. Substance P (SP) has been shown to modulate the immune response. In order to investigate the role of SP in liver injury and to determine whether it leads to pro-inflammatory signaling, we established a mouse model of hepatic injury induced by concanavalin A (ConA). We also exposed mouse Kupffer cells (KCs) to SP . Cytokine and SP levels in liver homogenates were detected using enzyme-linked immunosorbent assay (ELISA) and the protective effects of L-703,606 were evaluated through serological and histological assessments. Neurokinin-1 receptor (NK-1R) expression was evaluated by immunofluorescence and quantitative polymerase chain reaction (PCR). The levels of SP, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were significantly increased in the ConA-treated mice and the levels of ALT and AST were markedly reduced by L-703,606-pretreatment. Liver injury was significantly reduced by treatment with L-703,606. The mouse KCs expressed NK-1R and SP increased NK-1R mRNA expression. Furthermore, NK-1R blockade eliminated the effect of SP on NK-1R mRNA expression. The cytokine levels exhibited a substantial increase in the SP-pretreated KCs compared with the KCs that were cultured in control medium. The inter-leukin (IL)-6 and tumor necrosis factor (TNF)-α levels in the L-703,606-pretreated KCs were significantly lower compared with those in the SP-pretreated KCs. Our study suggests that neurogenic inflammation induced by SP plays an important role in hepatitis. Mouse KCs express NK-1R and SP increases NK-1R mRNA expression. SP enhances IL-6 and TNF-α secretion and an NK-1R antagonist inhibits this secretion.
Guizhi Fuling Wan ameliorates concanavalin A-induced autoimmune hepatitis in mice.
Kuo S, Su C, Lai K, Chang Y, You J, Peng H Biomed J. 2024; 48(1):100731.
PMID: 38677491 PMC: 11745949. DOI: 10.1016/j.bj.2024.100731.
Huo M, Zhang Q, Si Y, Zhang Y, Chang H, Zhou M Purinergic Signal. 2024; .
PMID: 38305986 DOI: 10.1007/s11302-024-09985-y.
Concanavalin A-induced autoimmune hepatitis model in mice: Mechanisms and future outlook.
Liu Y, Hao H, Hou T Open Life Sci. 2022; 17(1):91-101.
PMID: 35291566 PMC: 8886606. DOI: 10.1515/biol-2022-0013.
Dou B, Li Y, Ma J, Xu Z, Fan W, Tian L Front Neurosci. 2021; 15:695670.
PMID: 34408622 PMC: 8366064. DOI: 10.3389/fnins.2021.695670.
Wang J, Yu S, Li J, Li H, Jiang H, Xiao P Pharm Biol. 2019; 57(1):385-391.
PMID: 31184936 PMC: 6566838. DOI: 10.1080/13880209.2019.1617750.